We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
I am a...
IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie discusses the importance of relaxing and de-stressing over the summer months, but also highlights essentials to keep in mind: vaccination, mask-wearing, COVID-19 testing, anti-viral treatment prescriptions, and prudent travel planning for myeloma patients will ensure their safety. READ DR. DURIE'S BLOG.
The IMF team is providing these lecture-type video presentations to keep you updated on the latest developments in myeloma research from the 2022 ASCO Annual Meeting and EHA Congress. The IMF will be posting more video presentations, please check back for more updates. WATCH NOW.
The Best of 2022 ASCO & EHA: What Patients and Care Partners Need to Know will be on Thursday, July 7 at 4 p.m. PST/ 5 p.m. MT/ 6 p.m. CT/ 7 p.m. ET. In this 60-minute webinar, the IMF will be presenting highlights of the recently concluded 2022 ASCO Meeting and EHA Congress. REGISTER NOW.
The Brian D. Novis Research Grants are awarded to researchers working in the field of multiple myeloma and related disorders. 2023 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is on September 1, 2022. APPLY NOW.
The 2nd virtual M-Power Charlotte webinar was held on Saturday, June 25, where "Myeloma for Patients Who Are Just Getting Started," and the latest in myeloma treatments and research were discussed. In case you missed, you can still watch the replay. WATCH NOW.
On June 23, the Living Well with Myeloma Webinar focused on “A Promising Future for Treating Multiple Myeloma with Bispecific Antibodies.” In case you missed it, you can still watch the replay. WATCH NOW.
Our hearts go to all innocent victims of the ongoing conflict in Ukraine.
As a global organization, the International Myeloma Foundation supports — and will continue to support — every myeloma patient, caregiver, doctor, researcher, and advocate going through struggles and difficulties brought about by the war in Ukraine.
As an advocate for hope and resilience among the members of the myeloma community, the IMF is here for you — and even to a greater degree, during this most difficult time.
Our mission is clear, and our steadfast commitment continues — to improve the quality of life of myeloma patients across the globe, while working toward prevention and a cure.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!
